Kynurenic acid inhibits colon cancer proliferation in vitro: effects on signaling pathways

Area of Science:

• Biochemistry
• Molecular Biology
• Cancer Research

Background:

• Kynurenic acid (KYNA), a tryptophan metabolite, exhibits antiproliferative effects on various cancer cell lines.
• Previous research suggests KYNA's inhibitory properties stem from interactions with cell cycle regulators and signaling proteins.
• The precise molecular mechanisms of KYNA in colon cancer cells remain largely unelucidated.

Purpose of the Study:

• To investigate the molecular mechanisms underlying KYNA's inhibitory effects on colon adenocarcinoma HT-29 cells.
• To examine KYNA's impact on the phosphoinositide 3-kinase/Akt (PI3K/Akt) and mitogen-activated protein kinase (MAPK) signaling pathways.
• To explore KYNA's effects on the Wnt signaling pathway and β-catenin expression in colon cancer cells.

Main Methods:

• Treatment of HT-29 colon adenocarcinoma cells with Kynurenic acid (KYNA).
• Analysis of protein phosphorylation levels for Akt, ERK 1/2, and p38 kinases.
• Assessment of β-catenin protein expression and nuclear translocation.
• Evaluation of KYNA's combined effects with signaling pathway inhibitors (wortmannin, PD98059, SB202190, IWR-1).

Main Results:

• KYNA significantly decreased the phosphorylation of Akt, ERK 1/2, and p38 kinases in HT-29 cells.
• KYNA treatment led to increased β-catenin protein expression without promoting its nuclear translocation.
• KYNA potentiated the antiproliferative effects of wortmannin, PD98059, SB202190, and IWR-1 at millimolar concentrations.

Conclusions:

• KYNA inhibits key pro-survival signaling pathways (PI3K/Akt, MAPK) in colon cancer cells.
• KYNA exhibits complex interactions with the Wnt pathway, increasing β-catenin levels but not nuclear translocation.
• KYNA demonstrates potential as a chemopreventive agent or adjunct therapy for colon cancer, warranting further investigation into its Wnt pathway interactions.